Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus
Heikki Lukkarinen(University of Eastern Finland), Ville Leinonen(University of Eastern Finland), Darrel J. Pemberton(University of Southampton), Johannes Streffer(University of Antwerp), Kaj Blennow(Sahlgrenska University Hospital), Tuomas Rauramaa(University of Eastern Finland), Sebastiaan Engelborghs(Vrije Universiteit Brussel), Sanna‐Kaisa Herukka(University of Eastern Finland), Antti Junkkari(University of Helsinki), Hartmuth C. Kolb(Johnson & Johnson (United States)), Anne M. Koivisto(University of Helsinki), Astrid Bottelbergs(Janssen (Belgium)), Ina Tesseur(Stanford University), Henrik Zetterberg(University of Wisconsin–Madison), Mikko Hiltunen(University of Eastern Finland), Maarten Timmers, Luc Janssens(KU Leuven), Ville E. Korhonen(University of Eastern Finland), Peter van der Ark(Janssen (Belgium)), Luc Van Nueten(Janssen (Belgium)), Randy Slemmon(Janssen (United States))
Cited by 17
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k